Previous 10 | Next 10 |
RANCHO CUCAMONGA, CA / ACCESSWIRE / November 1, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2023 ended September 30, 2023, after the market closes on Wednesday, November 8, 2023, and will hold a conference call to ...
2023-10-10 21:41:26 ET Summary Amphastar Pharmaceuticals has implemented aggressive corporate strategies to maximize margins and increase sales, resulting in impressive EBIT and revenue growth. The company's focus on high-margin products and strategic acquisitions has contributed ...
2023-09-26 07:00:00 ET Summary Amphastar's Q2 2023 financials show an 18% YoY revenue growth and 50% net income increase, outpacing sector performance. Strategic $300M convertible senior notes offering aims to restructure debt and enable stock repurchases, potentially improving li...
2023-09-13 05:10:45 ET More on Amphastar Pharmaceuticals Financial information for Amphastar Pharmaceuticals Amphastar's Generic Drug Rush Gains Momentum Amphastar Pharma: A Company Growing Quickly As Acquisitions Likely Fuel Growth For further details see: ...
RANCHO CUCAMONGA, CA / ACCESSWIRE / September 13, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar") today announced the pricing of $300.0 million aggregate principal amount of 2.00% convertible senior notes due 2029 (the "notes") in a private placement to persons reasonably beli...
2023-09-11 16:58:16 ET More on Amphastar Pharmaceuticals Seeking Alpha’s Quant Rating on Amphastar Pharmaceuticals Historical earnings data for Amphastar Pharmaceuticals Financial information for Amphastar Pharmaceuticals Amphastar's Generic Drug Rush ...
RANCHO CUCAMONGA, CA / ACCESSWIRE / September 11, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar") today announced that it intends to offer, subject to market conditions and other factors, $300.0 million aggregate principal amount of convertible senior notes due 2029 (the "note...
RANCHO CUCAMONGA, CA / ACCESSWIRE / August 31, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, will participate in an Analyst-Moderated fireside chat at the Wells Fargo Healthcare Confer...
2023-08-08 20:35:05 ET Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2023 Earnings Conference Call August 08, 2023 05:00 PM ET Company Participants Dan Dischner - Senior Vice President of Corporate Communications Bill Peters - Chief Financial Officer & Executive Vice...
2023-08-08 16:37:21 ET Amphastar Pharmaceuticals press release ( NASDAQ: AMPH ): Q2 Non-GAAP EPS of $0.65 beats by $0.09 . Revenue of $145.7M (+18.0% Y/Y) beats by $8.73M . Cash flow provided by operating activities for the six months ended June 30, 2023 was $9...
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Complete Solaria Inc Com (CSLR) rose 58.5% to $1.775 on volume of 71,457,263 shares Senti Biosciences Inc. (SNTI) rose 55.1% to $0.428 on volume of 64,207,396 shares Golden Heaven Group Holdings Ltd. (GDHG) rose 13.3% to $0.1711 on vo...
2024-06-19 18:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...